Plain-English translation of NCT07405983 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing the TOUCH® CMC 1 Prosthesis, a new artificial joint replacement designed to treat osteoarthritis at the base of the thumb. The device was recently approved by the FDA, and this study is collecting real-world data to confirm it works safely and effectively in patients who receive it. If you have severe thumb arthritis that hasn't improved with other treatments, you may be eligible to participate.
While this treatment has been approved by the FDA, the agency requires the manufacturer to continue monitoring how well it works in actual patients over time. This study helps ensure the device remains safe and effective for everyone who receives it.
You likely qualify if…
You likely don't qualify if…
If you enroll, you would have surgery to remove the damaged joint and implant the new TOUCH® CMC 1 device. After surgery, you would attend follow-up visits with your surgeon to monitor how well the device is working, check for any complications, and assess your thumb function and pain levels. The study will track your recovery and long-term outcomes to help the FDA confirm the device's safety and effectiveness.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States